Navigation Links
Hebrew U. researchers shed light on the brain mechanism responsible for processing of speech
Date:8/12/2009

Researchers from the Hebrew University of Jerusalem have succeeded for the first time in devising a model that describes and identifies a basic cellular mechanism that enables networks of neurons to efficiently decode speech in changing conditions.

The research may lead to the upgrading of computer algorithms for faster and more precise speech recognition as well as to the development of innovative treatments for auditory problems among adults and young people.

Our brain has the capability to process speech and other complex auditory stimuli and to make sense of them, even when the sound signals reach our ears in a slowed, accelerated or distorted manner.

However, the neuronal mechanisms that enable our brain to perceive a word correctly, for example, that is pronounced in different ways by different speakers or to understand a heavy accent, was a mystery to scientists until now.

Research associate Dr. Robert Gtig and Prof. Haim Sompolinsky of the Edmond and Lily Safra Center for Brain Sciences at the Hebrew University have succeeded in describing a cellular process by which sensory neurons in the brain can automatically adjust their perceptual clocks and thus correct large temporal variations in the rate of sounds and speech that arrive from the environment.

According to their findings, which were recently published in the PLoS Biology journal, the bio-physical mechanism that exists in our brain enables single nerve cells in the cerebral cortex to perform word identification tasks almost perfectly.

The understanding of the process of speech decoding and the possibilities of its implementation in technology by the development of neural network algorithms for the identification and processing of various patterns of sound signals could lead to the significant upgrading of speech recognition technology in communications and computing, for instance in telephone voice dialing or in voice and sound
'/>"/>

Contact: Rebecca Zeffert
rebeccaz@savion.huji.ac.il
972-548-820-661
The Hebrew University of Jerusalem
Source:Eurekalert  

0

GOOD

Page: 1 2

Related biology news :

1. Promising new treatment for Alzheimers suggested based on Hebrew University research
2. Hebrew University researchers neutralize tumor growth in embryonic stem cell therapy
3. Hebrew University professors work leads to FDA approval for product
4. Hebrew University scientists reveal mechanism that triggers differentiation of embryo cells
5. Scent on demand: Hebrew University scientists enhance the scent of flowers
6. Hebrew University develops novel approach for treating mitochondrial disorders
7. Hebrew University study opening new route for combating viruses
8. Electronic structure of DNA revealed for 1st time by Hebrew University and collaborating researchers
9. Five young Hebrew University scientists win first competitive EU grants
10. Hebrew SeniorLife researchers search for aging, osteoporosis genes
11. Antioxidant to retard wrinkles discovered by Hebrew University researcher
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hebrew U. researchers shed light on the brain mechanism responsible for processing of speech
Hebrew U. researchers shed light on the brain mechanism responsible for processing of speech
(Date:12/16/2009)... iQor, a global provider of business process outsourcing (BPO) ... 100 Awards Top 100 IT project of 2009 for ... submission for iQor. ,, "We are honored to be ... Kapoor, president and CEO of iQor. "TeQ21 is completely ... work faster, smarter and with the added security biometrics ...
(Date:12/16/2009)... DigitalPersona, Inc., a leader in ... an agreement with IBM to deploy a ... technology on IBM SurePOS 500 retail systems. ... applications to more easily and quickly identify ... linked to the individuals who perform them. ...
(Date:12/16/2009)... Dec. 3 BIO-key International, Inc. ... wireless public safety and finger-based biometric identification ... shareholders at a Special Shareholder Meeting held ... Law Enforcement Division to Interact911 Mobile Systems ... cast in favor and 1.2% were opposed. ...
Breaking Biology News(10 mins):iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3SAFC Pharma Installs the Industrys First Commercial Dual Wavelength X Ray Diffractometer 5411 1SAFC Pharma Installs the Industrys First Commercial Dual Wavelength X Ray Diffractometer 5411 2SAFC Pharma Installs the Industrys First Commercial Dual Wavelength X Ray Diffractometer 5411 3Renowned Southern California Doctors Emphasizing Early Detection During Breast Cancer Awareness Month 59324 1Renowned Southern California Doctors Emphasizing Early Detection During Breast Cancer Awareness Month 59324 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 1Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 3Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 4Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 5Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 6Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 7Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 8
... cancer, is generally discouraged until the age at which ... children of BRCA mutation carriers learn of their parents ... indicated. , A new study in the ... and experiences of parental communication of BRCA results to ...
... , Individuals with chronic myeloid leukemia (CML) are ... which targets the protein known to cause the cancer ... that are resistant to the effects of imatinib, individuals ... which targets BCR-ABL in a different way. However, patients ...
... first time the atomic structure of an ancient protein, ... , "Never before have we seen so clearly, so ... an evolutionary biologist at the University of Oregon. "We ... evolution molded a tiny molecular machine at the atomic ...
Other Biology News:JCI table of contents: Aug. 16, 2007 2JCI table of contents: Aug. 16, 2007 3JCI table of contents: Aug. 16, 2007 4JCI table of contents: Aug. 16, 2007 5JCI table of contents: Aug. 16, 2007 6JCI table of contents: Aug. 16, 2007 7Scientists retrace evolution with first atomic structure of an ancient protein 2Scientists retrace evolution with first atomic structure of an ancient protein 3
(Date:12/15/2009)... China Sky One,Medical, Inc. ("China Sky One Medical" ... fully integrated pharmaceutical company developing and producing,over-the-counter drugs ... that the Company has 30 medicines that will ... Basic Medical Insurance, Industrial Injury Insurance,and Maternity Insurance ... 30 medicines treat a variety of common ailments ...
(Date:12/15/2009)... Microscopy (AFM) have been developed and are opening up a ... The NeedleProbes’ cylindrical geometry enables researchers to measure surface ... all in a single force distance curve. , ... ... diameter NeedleProbes are enabling unique measurements at the ...
(Date:12/15/2009)... N.Y., Dec. 15 On January 20th, ... Society for Medical Publication Professionals (ISMPP) will be ... London, UK. More than 100 attendees are expected ... for publication professionals, editors, publishers, medical writers and ... medical publications and the impact of guidelines and ...
(Date:12/14/2009)... THOUSAND OAKS, Calif., Dec. 14 Array ... Inc.(Nasdaq: AMGN ) today announced that they ... rights to Array,s small-molecule glucokinase activator program, including ... clinical trial in patients with Type 2 diabetes. ... agreement, Array will receive an upfront payment of ...
Breaking Biology Technology:China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... Both Clinical Trial Experience and Business ... CAMBRIDGE, Mass., Jan. 16 Cytel, Inc. ... Irving Dark has,accepted the role of Vice President ... Cytel 15-years of management experience guiding drug,biologic and ...
... ON, Jan. 16 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ... for the,fiscal year ended November 30, 2007. All ... otherwise noted., At November 30, 2007, our ... $30.4 million at November 30, 2006. The change ...
... ROG.VX; RO.S), a world-leading healthcare provider of,pharmaceuticals and diagnostics, ... all of the outstanding common shares of Ventana Medical,Systems, ... York City time on Friday,March 14, 2008. The tender ... York City time, on January 17, 2008. All other ...
Other Biology Technology:Irving Dark Named Vice President of Cytel Clinical Research Services 2Vasogen Announces 2007 Year-End Results 2Vasogen Announces 2007 Year-End Results 3Vasogen Announces 2007 Year-End Results 4Vasogen Announces 2007 Year-End Results 5Vasogen Announces 2007 Year-End Results 6Vasogen Announces 2007 Year-End Results 7Vasogen Announces 2007 Year-End Results 8Vasogen Announces 2007 Year-End Results 9Vasogen Announces 2007 Year-End Results 10Vasogen Announces 2007 Year-End Results 11Roche Extends Tender Offer for Ventana 2Roche Extends Tender Offer for Ventana 3Roche Extends Tender Offer for Ventana 4Roche Extends Tender Offer for Ventana 5